Stock UniverseDerived research view · source repositories remain read-only

NewAmsterdam Pharma Company N.V. (NAMS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.26
Global Rank
511
Market Cap
4.08B
Latest Close
31.52
RS Composite
-13.35% · G#2296

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
1.71%
3M
5.56%
6M
-11.26%
1Y
62.56%
3Y
127.42%
5Y
224.95%
10Y
197.02%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.08M · 30-day average: 1.56M · Max drawdown over stored range: -66.23%

Research Snapshot

Relative Strength vs SPX

RS Composite-13.35%
20D RS-10.19%
60D RS-8.43%
120D RS-19.85%
Global RS Rank2296 · 31.56% percentile
Qualified+ RS Rank869 · 30.92% percentile
Group ScopeQualified+
Primary RS Rank238 · 48.03% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank60 / 701
Primary Percentile91.58
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0722.57Mn/a-215.18M-212.73M-1.78-252.53M388.00K-252.91M120Mn/a-9.54%-9.43%-11.19%-11.21%636.11Mn/a

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-1.78-17.8x$0.19167.4x$-2.11-14.9x$-2.11-15.0x

Shares Diluted: 120M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0102.69414.0945.56322.503
Revenue Growth (YoY)2800%2800%-86.28%223.371%-50.611%
Gross Profit0102.69414.0945.56322.503
Operating Income-34.977-3.557-182.967-176.289-225.683
Free Cash Flow-29.53610.444-141.242-159.236-148.029
Free Cash Flow Per Share-2.690.551-1.719-1.688-1.25
EPS (Diluted) GAAP-3.805945-1.193383-2.153514-2.560438-1.721092
EPS Growth
EPS Non-GAAP
Gross Margin2800%100%100%100%100%
Operating Margin2800%-3.464%-1298.559%-386.913%-1002.902%
Profit Margin2800%-22.04%-1255.763%-530.25%-905.741%
Free Cash Flow Margin2800%10.17%-1002.427%-349.485%-657.819%
Shares Outstanding (Diluted)10.978918.966282.16294.3581118.4242
Shares Change (YoY)119.577%72.752%333.201%14.844%25.505%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-073.04Mn/a-58.42M-19.22%-48.44M-15.93%-0.40121.72M636.11Mn/aprocessed
2025 Q42026-02-1832.00Kn/a-65.98M-2061.88%-74.92M-2341.34%-0.62119.98M636.24Mn/aprocessed
2025 Q32025-11-05348.00Kn/a-55.14M-158.46%-72.00M-206.91%-0.61119.00M702.95Mn/aprocessed
2025 Q22025-08-0619.14Mn/a-35.63M-1.86%-17.36M-90.70%-0.15118.56M739.16Mn/aprocessed
2025 Q12025-05-082.98Mn/a-68.92M-23.14%-39.53M-13.27%-0.34116.12M808.48Mn/aprocessed
2024 Q42025-02-2612.77Mn/a-43.23M-3.38%-92.18M-7.22%-0.9399.43M834.19Mn/aprocessed
2024 Q32024-11-0629.11Mn/a-25.00M-85.89%-16.65M-57.18%-0.1894.75Mn/an/aprocessed
2024 Q22024-08-072.28Mn/a-52.58M-23.07%-39.01M-17.12%-0.4194.71Mn/an/aprocessed
2024 Q12024-05-081.40Mn/a-55.48M-39.60%-93.77M-66.93%-1.0688.38Mn/an/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.